Vir Biotechnology, Inc.VIRNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -26.29% | -94.62% | -60.52% | -89.92% | +417.78% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.63% | +1.62% | +1.62% | +1.67% | +1.77% |
| Weighted Average Shares Diluted Growth | +1.63% | +1.62% | +1.62% | +1.67% | +1.77% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | -29.41% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -27.11% | -27.10% | -28.57% | -31.96% | -28.31% |
| Book Value per Share Growth | -28.82% | -33.62% | -34.97% | -36.89% | -34.63% |
| Debt Growth | -21.40% | -20.64% | -10.73% | -11.20% | +90.93% |
| R&D Expense Growth | -2.65% | +18.50% | -7.23% | -22.40% | -16.72% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |